How can we unlock the full potential of omics to transform disease prevention and treatment? Intrepid research teams are working to link the microbiome, metabolome, and immunome to disease risk, prognosis, and therapy response. This session convenes scientists, regulators, and technologists to discuss the latest breakthroughs, data and infrastructure needs, and the pathways to turn complex omic mapping into actionable insights for patients. This session was developed in partnership with the Human Immunome Project, Moonshot Exposome (Johns Hopkins), and FidoCure.

Speakers

• Jane Metcalfe, Executive Chair, Human Immunome Project

• Thomas Hartung, Chair Professor, Johns Hopkins Bloomberg School of Public Health

• Christina Lopes, Co-founder & CEO, FidoCure

• Shai Shen-Orr, Co-CSO, Human Immunome Project